U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of the Chief Scientist
  6. National Center for Toxicological Research
  7. Science & Research (NCTR)
  8. NCTR Research Focus Areas
  9. AnimalGAN Initiative
  1. NCTR Research Focus Areas

AnimalGAN Initiative

Initiative to develop virtual animal models to simulate animal study results using AI.

Image
AnimalGAN Logo

AnimalGAN | SafetAI | BERTox | PathologAI

Objective: To develop virtual animal models to simulate animal study results using artificial intelligence (AI).

Introduction: Testing data from animal models provide crucial evidence for the safety evaluation of chemicals. These data have been an essential component in regulating drug, food, and chemical safety by regulatory agencies around the world. As a result, a wealth of animal data are available from the public domain and other sources. As the toxicology community and regulatory agencies move towards a reduction, refinement, and replacement (3Rs principle) of animal studies, we are exploring an AI-based generative adversarial network (GAN) architecture to learn from existing animal studies to generate animal data without conducting additional animal experiments.

Approaches: We are developing a GAN method that can generate animal-study data which otherwise would have to be obtained with actual animal studies. In a pilot study, we demonstrated that synthetic data from AnimalGAN for toxicogenomics, hematology, and clinical chemistry has the potential to be used in toxicity assessments, mechanistic studies, and biomarker development similar to actual experimental data. 

Potential Impact: Conventional animal studies can be expensive, time-consuming, labor-intensive, and raise ethical concerns. AnimalGAN is an AI-based suite to generate specific animal-study datasets for new and untested chemicals by learning from legacy animal-study data. Thus, it could supplement animal studies by screening new and untested chemicals to guide and refine subsequent animal experiments in risk assessment and safety evaluation.

References

Year Title Authors Full Citation
2023 A Generative Adversarial Network Model Alternative to Animal Studies for Clinical Pathology Assessment. Chen X., Liu Z., and Tong W. A Generative Adversarial Network Model Alternative to Animal Studies for Clinical Pathology Assessment.
Chen X., Liu Z., and Tong W.
Nature Communications. 2023, 14, 7141.
doi: 10.1038/s41467-023-42933-9.
2023 TransOrGAN: An Artificial Intelligence Mapping of Rat Transcriptomic Profiles between Organs, Ages, and Sexes Li T., Roberts R., Liu Z., and Tong W.  TransOrGAN: An Artificial Intelligence Mapping of Rat Transcriptomic Profiles between Organs, Ages, and Sexes
Li T., Roberts R., Liu Z., and Tong W. 
Chemical Resesarch in Toxicology. 2023, 36(6):916-925.
doi: 10.1021/acs.chemrestox.3c00037.
2022 Tox-GAN: An Artificial Intelligence Approach Alternative to Animal Studies—A Case Study With Toxicogenomics. Chen X., Roberts R., Tong W. et al. Tox-GAN: An Artificial Intelligence Approach Alternative to Animal Studies—A Case Study With Toxicogenomics.
Chen X., Roberts R., Tong W. et al.
Toxicological Sciences. 2022,186:242-259.

Resources for You

Subscribe to receive info on NCTR Bioinformatics Tools

Get regular FDA email updates delivered on this topic to your inbox.

Back to Top